A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
The breakpoints of Df(1)BSC756 predicted from the Release 5 genomic coordinates of the insertion sites of the progenitor transposable elements PBac{WH}Graff02954 and P{XP}sdd04263 are X:15652384 ;15708694 and the cytological breakpoints predicted from these coordinates are 13E14;13F1.